Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126632341 | 12663234 | 1 | I | 20160727 | 0 | 20160817 | 20160817 | DIR | 91.00 | YR | F | N | 165.00000 | LBS | 20160816 | Y | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126632341 | 12663234 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 1 TABLET(S) IN THE MORNING TAKEN BY MOUTH | N | D | 0 | 1 | DF | COATED TABLET | |||||
| 126632341 | 12663234 | 3 | C | LEVIMIR FLEXTOUCH PEN | 2 | 0 | |||||||||||||
| 126632341 | 12663234 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 126632341 | 12663234 | 7 | C | AGGRENOX | ASPIRINDIPYRIDAMOLE | 1 | 0 | ||||||||||||
| 126632341 | 12663234 | 9 | C | POTASSIUM CL | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 126632341 | 12663234 | 11 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 126632341 | 12663234 | 13 | C | ROLLATOR, LIFT CHAIR | 2 | 0 | |||||||||||||
| 126632341 | 12663234 | 15 | C | OSTEO BI-FLEX TRIPLE STRENGTH | 2 | 0 | |||||||||||||
| 126632341 | 12663234 | 17 | C | CALCIUM 600+D | CALCIUMVITAMIN D | 1 | 0 | ||||||||||||
| 126632341 | 12663234 | 19 | C | MULTI FOR HER WITH IRON | 2 | 0 | |||||||||||||
| 126632341 | 12663234 | 21 | C | ALOE VERA CAPSULE | 2 | 0 | |||||||||||||
| 126632341 | 12663234 | 23 | C | FISH OIL | FISH OIL | 1 | 0 | ||||||||||||
| 126632341 | 12663234 | 25 | C | CALCIUM/MAGNESIUM/ZINC | 2 | 0 | |||||||||||||
| 126632341 | 12663234 | 27 | C | JOINT ADVANTAGE GOLD | 2 | 0 | |||||||||||||
| 126632341 | 12663234 | 29 | C | BIOTIN | BIOTIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126632341 | 12663234 | 1 | Blood glucose increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126632341 | 12663234 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126632341 | 12663234 | Arthralgia | |
| 126632341 | 12663234 | Dermatitis allergic | |
| 126632341 | 12663234 | Erythema | |
| 126632341 | 12663234 | Impaired driving ability | |
| 126632341 | 12663234 | Peripheral swelling | |
| 126632341 | 12663234 | Quality of life decreased | |
| 126632341 | 12663234 | Skin disorder | |
| 126632341 | 12663234 | Skin ulcer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126632341 | 12663234 | 1 | 20160323 | 20160725 | 0 |